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Abstract 
Background: Wound healing represents a dynamic process involving directional migration of different cell types. 
Chemokines, a family of chemoattractive proteins, have been suggested to be key players in cell‑to‑cell communica‑
tion and essential for directed migration of structural cells. Today, the role of the chemokine network in cutaneous 
wound healing is not fully understood. Unraveling the chemokine‑driven communication pathways in this complex 
process could possibly lead to new therapeutic strategies in wound healing disorders.
Methods: We performed a systematic, comprehensive time‑course analysis of the expression and function of a 
broad variety of cytokines, growth factors, adhesion molecules, matrixmetalloproteinases and chemokines in a murine 
cutaneous wound healing model.
Results: Strikingly, chemokines were found to be among the most highly regulated genes and their expression 
was found to coincide with the expression of their matching receptors. Accordingly, we could show that resting and 
activated human primary keratinocytes (CCR3, CCR4, CCR6, CXCR1, CXCR3), dermal fibroblasts (CCR3, CCR4, CCR10) 
and dermal microvascular endothelial cells (CCR3, CCR4, CCR6, CCR8, CCR9, CCR10, CXCR1, CXCR2, CXCR3) express a 
distinct and functionally active repertoire of chemokine receptors. Furthermore, chemokine ligand–receptor interac‑
tions markedly improved the wound repair of structural skin cells in vitro.
Conclusion: Taken together, we here present the most comprehensive analysis of mediators critically involved in 
acute cutaneous wound healing. Our findings suggest therapeutic approaches for the management of wound clo‑
sure by targeting the chemokine network.
Keywords: Chemokines, Chemokine receptors, Wound healing, Skin, Keratinocyte, Fibroblast, Endothelial cell, 
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Background
Wound healing is a complex phenomenon that requires 
an integrated network of repair mechanisms, includ-
ing cell migration, proliferation and cellular production 
of structural molecules essential for tissue regeneration. 
The tissue response to injury is characterized by three 
overlapping phases: (a) Inflammation, (b) granulation 
and (c) matrix remodeling [1]. These phases involve a 
dynamic cascade of events including clotting and hemo-
stasis, leukocyte recruitment, tissue formation, epithe-
lialization, angiogenesis, collagen synthesis and wound 
contraction [1]. The major cell types involved in cutane-
ous wound healing span from hematopoietic cells such 
as blood platelets, immune regulators like neutrophils, T 
cells, dendritic cells and macrophages, to structural cells 
like fibroblasts, endothelial cells and keratinocytes [1–6]. 
Specifically, wound repair is regulated by a highly orches-
trated interplay of cytokines, growth factors, extracellu-
lar matrix and more recently described chemokines [2, 3, 
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6–15]. Chemokines and their receptors play a crucial role 
in development, homeostasis, tumor development and 
most notably wound healing and angiogenesis [16–18].
Chemokines are small, secreted proteins which medi-
ate directional migration and regulate leukocyte traffick-
ing [19–21]. Notably, the chemokine family is likely to 
be one of the first complete protein superfamilies that 
has been identified and characterized at molecular level 
[22]. This presents the opportunity to identify all relevant 
members of the chemokine superfamily involved in com-
plex biological processes such as wound healing.
The aim of this work was to investigate the com-
plex interactions of chemokines and their receptors 
in cutaneous wound healing. We systematically meas-
ured cytokines, growth factors, adhesion molecules, 
matrixmetalloproteinases and chemokines in a murine 
model for acute cutaneous wound healing. Strikingly, 
a subset of chemokines proved to be among the most 
highly regulated genes. The chemokine expression is 
highly orchestrated and coincides with the appearance 
of matching receptors. Accordingly, we demonstrate that 
structural cells, such as human keratinocytes, dermal 
fibroblasts and dermal microvascular endothelial cells, 
express a distinct and functionally active repertoire of 
chemokine receptors. Furthermore, migration assays sug-
gest that chemokines and their cognate receptors acceler-
ate wound healing via chemotaxis of structural cells.
Methods
Cell culture
Human primary epidermal keratinocytes, dermal fibro-
blasts, melanocytes and dermal microvascular endothe-
lial cells were purchased from Clonetics (San Diego, CA) 
and cultured in keratinocyte (KGM-2), fibroblast (FGM-
2), or endothelial cell (EGM-2) growth medium (all Clo-
netics, San Diego, CA) [23]. We have used 2 × 104 cells 
for the culture and let it grow up to 80% confluence. 
Cells were treated with TNF-α (10  ng/ml)/IL-1β (5  ng/
ml) (R&D Systems Inc., Minneapolis, MN) for 10 to 12 h 
or left untreated. RNA was extracted from cells immedi-
ately, after 8 and 18 h as described later.
Quantitative real time PCR analysis
Quantitative real-time PCR analyses were performed 
as previously described [21, 24, 25]. Skin biopsies were 
homogenized in liquid nitrogen and RNA was extracted 
with RNAzol according to the manufacturer’s protocol 
(Tel-Test, Friedensburg, TX). 4  μg of RNA was reverse 
transcribed using standard protocols. 25  ng of cDNA 
was amplified in the presence of 12.5  μl of  TaqMan® 
universal master mix (Applied Biosystems, Foster City, 
CA), 0.625 μl of gene-specific  TaqMan® probe, 0.5 μl of 
gene-specific forward and reverse primers, and 0.5  μl 
of water. As an internal positive control, 0.125 μl of 18S 
RNA-specific  TaqMan® probe and 0.125 μl of 18S RNA-
specific forward and reverse primers were added to each 
reaction. Gene-specific probes used FAM™ as reporter 
dye, whereas probes for the internal positive control 
(18S RNA) were associated with the VIC™ reporter dye. 
Alternatively, 25 ng of cDNA was amplified using target-
specific primer combinations and SYBR green master 
mix (Applied Biosystems, Foster City, CA). Chemokine 
ligand- and receptor-specific primers and target-specific 
probes were obtained from Applied Biosystems (Foster 
City, CA). Gene-specific PCR products were measured 
by means of an ABI  PRISM® 7700 or 5700 Sequence 
Detection Systems (Applied Biosystems, Foster City, CA) 
continuously during 40 cycles. Target gene expression 
was normalized between different samples based on the 
values of the expression of the internal positive control 
(18S RNA) or ubiquitin.
Flow cytometry
To analyze chemokine receptor expression of non-hemat-
opoietic cells, cultured primary epidermal keratinocytes, 
dermal fibroblasts and dermal microvascular endothe-
lial cells from different donors were analyzed using flow 
cytometry and the following monoclonal antibodies 
(mAb): PE-conjugated anti-CCR1 (53,504.111, IgG2β), 
CCR2 (48,607.211, IgG2β), CCR3 (61,828.111, IgG2α), 
CCR7 (150,503, IgG2α), CCR9 (112,509, IgG2α), CXCR4 
(12G5, IgG2α), CXCR5 (51,505, IgG2α), CXCR6/STRL33 
(56,811, IgG2β) all R&D Systems, Mineapolis, MN. 
CCR4 (1G1.1, IgG1), CCR5 (2D7/CCR5, IgG2α), CCR6 
(11A9, IgG1) CXCR1 (5A12, IgG2β), CXCR2 (6C6, IgG1), 
CXCR3 (1C6/CXCR3, IgG1) all Pharmingen, San Diego, 
CA, CCR8 (Goat, IgG) Alexis Biochemicals, Grünberg, 
Germany, CCR10 (1908, IgG1) DNAX Research Inc., 
Palo Alto CA (or appropriate isotype controls (Pharmin-
gen, San Diego, CA and R&D Systems, Mineapolis, 
MN, Jackson ImmunoResearch Laboratories, Inc., West 
Grove, PA, USA). Briefly,  106 cells were stained with anti-
chemokine receptor mAb or isotype and analyzed using 
a FACScan and CELLQuest software (Becton Dickinson, 
San Jose, CA).
In vitro wound repair assay
2 × 104 human primary dermal fibroblasts, 2 × 104 der-
mal microvascular endothelial cells and 2 ×  104 epider-
mal keratinocytes were cultured in 24-well plates in 
FGM-2, EBM-2 and KGM-2 (Clonetics, San Diego, CA) 
medium and grown to confluency analogously to the pre-
viously described cultivation. The medium was removed 
and a single path wound was made with a sterile pipette 
tip through the intact cell layer. The width of the wound 
was 200  µm. Medium supplemented with or without 
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CCL1/I-309, CCL11/eotaxin, CCL17/TARC, CCL20/
MIP-3α, CXCL8/IL-8, CXCL9/MIG, CXCL10/IP-10 for 
keratinocytes, CCL1/I-309, CCL11/eotaxin, CCL17/
TARC, CCL27/CTACK for dermal fibroblasts and 
CCL1/I-309, CCL11/eotaxin, CCL17/TARC, CCL20/
MIP-3α, CCL27/CTACK, CXCL8/IL-8, CXCL9/MIG, 
CXCL10/IP-10 for dermal microvascular endothelial 
cells was added to each well. To confirm the involve-
ment of G(i) alpha protein-coupled receptor signaling in 
chemokine-induced wound repair responses, structural 
cells were pre-incubated with or without pertussis toxin 
(100 ng/ml PTX, Calibochem, Germany) 10–12 h before 
injury and chemokine stimulation. The status of the sin-
gle path wound was determined immediately as well as 
8 and 12  h after the wounding using a digital camera 
system (Olympus, Hamburg, Germany), or was moni-
tored for 12–18 h by time lapse video microscopy system 
(inverse Leitz Microscope with cell culture equipment, 
Zeiss AxioCam HRc, Zeiss AxioVision Software, Carl 
Zeiss, Oberkochen, Germany).
Cutaneous wound healing model
A total of 27 (3 mice per defined time point) female 
BALB/c mice were anesthetized with an intraperito-
neal injection of ketamine (120 mg/kg bw) and xylazine 
(16  mg/kg bw). The lumbar region was shaved and the 
surgical area was disinfected with betadine and isopro-
panol. Full-thickness 2  cm dorsal incisions were made 
with a scalpel through the epidermis and dermis leav-
ing the subcutaneous muscle layer undisturbed. Wounds 
were closed using a single 5 W surgical staple. Mice were 
euthanized by  CO2 inhalation 6, 12, 18 h, 1, 2, 3, 5, 7, and 
10 days after incisions were done. At the time of harvest, 
dorsal pelts surrounding the incisions were removed and 
normal skin was trimmed to 1–2  mm of incision. One 
half of each sample was placed in 10% buffered forma-
lin and processed for paraffin embedding. The other half 
of each sample was snap frozen in liquid nitrogen and 
processed for RNA extraction. Each cohort consisted 
of three animals and the subsequent experiment was 
repeated twice.
All experiments with mice were carried out after exam-
ination by the local ethics committee of the University of 
Düsseldorf and after an internal identification number 
was given. The tests were carried out by trained person-
nel, who respect the internal and international guidelines 
for animal research (e.g. ARRIVE Guidelines).
Patients
This study was approved by the local ethics committee 
and informed consent was secured from all patients par-
ticipating in this study. A total of 4 patients were included 
in the study. Skin biopsies were taken from either healthy 
individuals or patients undergoing surgery and secondary 
wound healing. Prior, 24 h, 2, 3, 5, 7, 9 and 12 days after 
radical surgery for acne inversa, biopsies were taken from 
the non-lesional wound edges. Skin samples were imme-
diately frozen in liquid nitrogen and stored at – 80 °C.
Histology and immunohistochemistry
Frozen skin samples, cut to a thickness of 6 µm on a cry-
omicrotome, were used for immunohistochemical analy-
ses of human secondary wound healing, skin sections 
were fixed with 3% acetone and preprocessed with  H2O2 
followed by an avidin and biotin blocking step (VECTOR 
Blocking Kit). Sections were stained with monoclonal 
antibodies against CCR2α, CCR2β, CCR3, (all polyclonal 
goat IgG), CCR4 (rabbit IgG), CCL1/I-309, CCL11/
eotaxin, CCL24/eotaxin-2 (goat IgG) (all Santa Cruz Bio-
technology Inc., Santa Cruz, CA, USA), CD31 (JC/70A, 
mIgG1), CD68 (KP1, mIgG1) (DAKOCytomation, Ham-
burg, Germany), CCL4/MIP-1β, CCL17/TARC, CCL18/
DC-CK1, CCL20/MIP-3α, CCL27/ALP (124,302.11; 
mIgG2α), CXCL9/MIG, CXCL10/IP-10 (all goat IgG), 
CXCL12/SDF-1α (K15C; mIgG1; Unite d’Immunologie 
Virale, Institute Pasteur, Paris, France), CCR1 
(53,504.111; IgG2β), CCR5 (45,549.111; mIgG2β), CCR6 
(53,103.111; mIgGβ), CXCR1 (42,705.111; mIgG2α), 
CXCR2 (48,311.111; mIgG2α), CXCR3 (49,801.111; 
mIgG1), CXCR4 (44,716.111; mIgG2α), CXCL10/IP-10, 
CXCL9/MIG, CCL17/TARC (all goat IgG) all R&D Sys-
tems, Minneapolis, MN), CXCL8/IL-8 (B-K8; mIgG2α) 
(Diaclone Res., France), CCR8 and CCR10 (German 
Cancer Research Center, Heidelberg, Germany) at 4oC. 
The staining was performed with an ABC-Kit (VECTOR 
Vectastain ABC-Kit) and an ACE-Kit (VECTOR). Sec-
tions were counterstained with hematoxylin. The immu-
nohistochemical examinations were conducted by three 
independent pathologists. If there were differences in the 
evaluation, a joint result was finally established.
Results
The dynamic network of chemokines in murine cutaneous 
wound healing
To elucidate the dynamic network of mediators control-
ling the highly orchestrated process of cutaneous wound 
healing, we performed comprehensive real-time PCR 
analyses of more than 100 genes including cytokines, 
growth factors, adhesion molecules, matrix-metallopro-
teinases and chemokines in a murine model of cutaneous 
wound healing (Fig. 1).
Based on the cytokines studied, along with IL-6 the 
IL-1 family members IL-1α and IL-1β showed the 
highest-fold upregulation after skin injury. IL-6 and 
TNF-α exhibited early peaks of expression after 6 or 
18  h while IL-1 family members and IFN-γ, IL-7, IL-11 
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showed maximal upregulation at days 2–3 (Fig.  1a). 
Among growth factors, platelet-derived growth fac-
tor (PDGF)-β, transforming growth factor (TGF)-β and 
granulocyte-colony stimulating factor (G-CSF) showed 
highest fold-increases in mRNA expression (Fig. 1a). The 
maximum expression of members of the growth factor 
Fig. 1 Differential expression of more than 100 genes involved in wound healing. A subset of chemokines is among the most highly regulated 
genes in wound healing. Quantitative real‑time RT‑PCR analyses of a cytokine, b chemokine, c matrix‑metalloproteinase (MMP) and d adhesion 
molecule expression in cutaneous wound healing. Skin specimens of BALB/c mice were taken before or 6, 12, 18 h, 1, 2, 3, 5, 7, or 10 days after full 
thickness skin incision. Target gene expression is shown as fold increase compared to healthy skin. Representative data of two independent experi‑
ments
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superfamily was observed during the transition from the 
inflammatory to the tissue formation phases at days 2–5. 
Within the family of matrix-metalloproteinases, MT1-
MMP, MMP-10 (stromelysin-2), lactoferrin, MMP-9 and 
MMP-8 showed the highest fold upregulation (Fig.  1c). 
Several members of the integrin/adhesion molecule fam-
ilies were upregulated following skin injury with α4 and 
β7 integrins showing the most prominent upregulation 
(Fig.  1d). However, this may be misleading since some 
members of the integrin superfamily such as β1 integrin 
exhibit significant homeostatic expression in skin that 
translates into a lower fold-upregulation following injury.
Among all genes studied, the members of the 
chemokine superfamily are belonging to the highly 
regulated transcripts during cutaneous wound heal-
ing. In particular, the CC chemokines CCL3/MIP-1α 
and CCL4/MIP-1β were upregulated more than 1000-
fold in injured compared to normal skin (Fig.  1b). Next 
to the chemokine ligands also significant increases of 
transcripts of their matching receptors (CXCR2, CCR1, 
CCR5) could be detected (Fig. 1b). The temporal kinetics 
of mRNA expression underscored the tightly regulated 
and orchestrated process of wound healing.
Three distinct expression patterns were recognized 
among the chemokines. First, chemokines which reached 
maximal upregulation within hours after initial trauma 
and subsequently disappeared during the following days 
(MIP-2, CCL3, CCL4, CCL2/MCP-1, CCL7/MCP-3, 
CCL11/eotaxin, CXCL10/IP-10, XCL1/Lymphotactin, 
CCR1, CXCR2) (Fig. 1b); second, members of this family 
of chemoattractive proteins which showed early upregu-
lation but peak expression between days 3 and 5 (CCL5/
RANTES, CXCL9/Mig, CXCL12/SDF-1, CCR2, CCR3, 
CCR5, CXCR3, CXCR4); third, chemokines which were 
overexpressed during the tissue formation and remod-
eling phase of cutaneous wound healing (> day 5; CCR6, 
CX3CR1). Notably, chemokine receptors closely followed 
the expression of their matching ligands (e.g. MIP-2-
CXCR2, CCL3-CCR1, CCL5-CCR5).
Since fold-difference of expression does not indicate 
the abundance of transcripts present at a particular site, 
we additionally studied the absolute expression levels of 
target chemokines and their receptors. Absolute mRNA 
levels determined using real-time quantitative RT-PCR 
showed that MIP-2, CCL3 and CCL4 were not only the 
most highly regulated chemokines during cutaneous 
wound healing, but also showed the highest abundance 
of transcripts during the inflammatory phase of the heal-
ing process (Fig. 2a, h, o). Notably, their receptor expres-
sion mirrored the expression kinetics of the ligands 
(Fig.  2b, k, q). Next to the highly regulated chemokines 
MIP-2, CCL3 and CCL4, other chemokine ligands 
and their receptors also showed interesting expression 
patterns. CXCR3 was upregulated within hours after 
incision, showing peak expression between days 2 and 3 
and remained upregulated until day 10 (Fig.  2t). While 
the CXCR3 ligand CXCL10 showed early and rapid 
upregulation within hours after injury, another CXCR3 
ligand, CXCL9, showed delayed induction and persisting 
upregulation during cutaneous wound healing. Similar 
patterns could be observed for CCR2, CCR3 and CCR5 
ligands (Fig. 2c, e, f, h, i). CCL2 showed a peak upregu-
lation 12  h after incision, whereas the maximum of the 
corresponding CCR2 expression was reached at day 2. 
While CXCL12 and CXCR4 already showed a significant 
homeostatic expression in the skin, this ligand–receptor 
pair was still upregulated in an equivalent fashion reach-
ing a peak at day 3 (Fig. 2u, v).
Chemokine receptor profile of structural cells: 
keratinocytes, fibroblasts and endothelial cells
As mentioned above, structural cells such as keratino-
cytes, fibroblasts and endothelial cells undergo sub-
stantial migration processes during wound healing. 
Observations made in the mouse imply that chemokine 
ligand–receptor interactions play an important role in 
cutaneous wound healing. Therefore, we next sought 
to systematically characterize the chemokine recep-
tor expression panels (CCR1-CCR10, CXCR1-CXCR6) 
of structural cells of the human skin in further detail 
(Table  1; Additional file  1: Figure S1–3). Since primary 
cytokines such as IL-1-family members and TNF-α are 
induced during the wound healing process, a cocktail 
of IL-1β plus TNF-α was used to mimic the stimulatory 
microenvironment during early cutaneous wound heal-
ing. Using flow cytometric analyses, we found that cul-
tured human primary resting and IL-1β/TNF-α-activated 
keratinocytes showed distinct expression of CCR4, 
CCR6, CCR9, CXCR1 and CXCR3 as well as low levels of 
CCR3 (Table 1; Additional file 1: Figure S1), while dermal 
fibroblasts expressed CCR3, CCR4 and CCR10 on their 
cell surface (Table  1; Additional file  1: Figure S2). Cul-
tured human primary dermal microvascular endothelial 
cells also showed a distinct pattern of chemokine recep-
tors on their cell surface including CCR3, CCR4, CCR6, 
CCR8, CCR9, CCR10, CXCR1, CXCR2, and CXCR3 
(Table  1; Additional file  1: Figure S3). No significant 
change in regulation was detected in cultured structural 
cells 12–24  h after IL-1β/TNF-α activation. As a trend, 
cytokine activation appeared to downmodulate rather 
than increasing cell surface expression of chemokine 
receptors. It is important to note that there was some 
degree of variability in the levels of chemokine recep-
tor expression depending on different donors and the 
relative confluence of primary cell cultures; however, the 
overall picture of cell surface expression was not affected.
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Fig. 2 The chemokine and chemokine receptor expression is temporally regulated during cutaneous wound healing. Quantitative real‑time PCR 
analyses of absolute levels of chemokine gene expression in cutaneous wound healing (a–v). Skin specimens of BALB/c mice were taken before 
or 12, 24 h, 2, 3, 5, 7, or 10 days after full thickness skin incision. Absolute values of gene expression were expressed as fg of target gene in 25 ng of 
total cDNA
Table 1 Chemokine receptors expressed by cultured human primary keratinocytes, dermal fibroblasts and dermal micro-
vascular endothelial cells
Flow cytometry was performed with PE-labeled anti-chemokine receptor mAbs directed against CCR1 to CCR10 and CXCR1 to CXCR6 or specific isotype controls using 
cultured primary cells. Representative results of three different donors
CCR CXCR
1 2 3 4 5 6 7 8 9 10 1 2 3 4 5 6
Keratinocytes – – + + – + – – + – + – + – – –
Fibroblasts – – + + – – – – – + – – – – – –
Endothelial cells – – + + – + – + + + + + + – – –
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Regulation of relevant chemokine ligands in structural 
cells
Chemokine receptors and their respective ligands are dif-
ferentially regulated in a highly coordinated fashion dur-
ing murine cutaneous wound healing. Accordingly, we 
have demonstrated that resting as well as activated struc-
tural cells of the human skin express distinct patterns of 
chemokine receptors. To now identify the putative cel-
lular origin and the regulatory patterns of the respec-
tive chemokine ligands in human skin cells, we next 
preformed systematic quantitative real-time PCR analy-
ses in resting and TNF-α/IL-1β-activated keratinocytes, 
dermal fibroblasts and dermal microvascular endothe-
lial cells. Strikingly, an array of chemokines showed 
homeostatic expression in structural cells, i.e. CCL20/
MIP-3α and CCL27/CTACK in keratinocytes, CCL13/
MCP-4 and CCL26/eotaxin-3 in dermal fibroblasts and 
CCL1/I-309 and CCL24/eotaxin-2 in dermal microvas-
cular endothelial cells (Fig.  3). In  vitro, the MCP-family 
members CCL2, CCL7, CCL8/MCP-2, and CCL13 as 
well as CCL11, CCL26 were markedly induced by IL-1β/
TNF-α in cultured dermal fibroblasts (Fig.  3). Interest-
ingly, analyses of structural cells of the skin suggested 
that CCL13 expression is restricted to dermal fibroblasts 
(Fig.  3). CCL1, CCL5, CCL3, CCL4, CXCL2/GRO and 
CXCL8 showed dominant induction in dermal micro-
vascular endothelial cells. Notably, CXCL8 showed high 
expression in dermal microvascular endothelial cells but 
not in cultured keratinocytes (Fig. 3).
In vitro, TNF-α/IL-1β-stimulation resulted in marked 
upregulation of the CXCR3 ligands CXCL9, CXCL10, 
and CXCL11 in endothelial cells, fibroblasts and to a 
lower degree in keratinocytes.
Keratinocytes constitutively produced high levels of 
CCL20 and CCL27 transcripts which were highly-induci-
ble by primary proinflammatory cytokines.
Chemokines mediate wound repair of structural cells 
in vitro
To now test the functional implications of our expres-
sion analyses, we next sought to perform in vitro wound 
repair assays. Therefore, we studied the effects of rel-
evant chemokines on primary keratinocytes, dermal 
fibroblasts and dermal microvascular endothelial cells in 
assays which were designed either as “end-time”-Assay 
or as continuously monitored assay with timelapse video 
microscopy (Fig.  4). Briefly, structural cells were grown 
to confluency and single path wounds were generated. 
As wound injury repair is mediated by migration within 
the first 24 h and cell proliferation occurs later than 36 h, 
wound closure was monitored and determined 12–18 h 
after injury.
Cultured keratinocytes express CXCR1, CXCR3, 
CCR4, CCR6 and CCR9 on their cell surface. The strong-
est chemokine-induced wound repair of keratinocytes 
could be achieved with the CCR6 ligand CCL20 and the 
CXCR3 ligand CXCL10 with dose-dependent closure of 
single path wounds within 12 h (Table 2, Fig. 4). Weaker 
but significant responses could be observed for CXCL8, a 
CXCR1 ligand, and CCL11, which binds to CCR3. How-
ever, stimulation of keratinocytes with the CCR4 ligand 
CCL17/TARC resulted only in variable enhancement of 
Fig. 3 Chemokine ligands are differentially regulated in resting and TNF‑α/IL‑1β‑activated keratinocytes, dermal fibroblasts and dermal microvascu‑
lar endothelial cells (a-s). Quantitative real‑time PCR analyses of absolute levels of chemokine gene expression of resting and activated (TNF‑α, IL1‑
β) human primary keratinocytes (KC), dermal fibroblasts (FB) and dermal microvascular endothelial cells (DEC). Absolute values of gene expression 
were expressed as fg of target gene in 25 ng of total cDNA
Page 8 of 17Bünemann et al. Eur J Med Res  (2018) 23:4 
wound repair (Table  2). No repair responses could be 
observed in cultured keratinocytes when an ‘irrelevant’ 
(receptor-negative) ligand such as CXCL12 (CXCR4 
ligand) was present (Table 2).
Cultured dermal fibroblasts express CCR3, CCR4 and 
CCR10. Accordingly, CCL11 (CCR3 ligand), CCL17 
(CCR4 ligand) and CCL27 (CCR10 ligand) induced sig-
nificant migration of cells into single path wounds leading 
to enhanced wound repair while ‘irrelevant’ chemokines 
such as CCL3 (CCR1 and CCR5 ligand) failed to induce 
responses (Table 2).
Cultured dermal microvascular endothelial cells, 
finally, that were shown to express the broadest 
chemokine receptor expression pattern (CCR3, CCR4, 
CCR6, CCR8, CCR9, CCR10, CXCR1, CXCR2, CXCR3) 
among structural cells of the skin presented markedly 
enhanced wound repair responses after stimulation with 
CCL1 (CCR8 ligand), CCL11 (CCR3 ligand) and CCL27 
(CCR10 ligand) (Table 2). Variable results were obtained 
with CXCL8 (CXCR1 and CXCR2 ligand). Although 
dermal microvascular endothelial cells expressed signifi-
cant levels of CCR6 and CXCR3 on their cell surface, no 
enhancement of wound repair was observed with their 
ligands CCL20 and CXCL10 (Table  2). Notably, instead 
of promoting endothelial migration and angiogen-
esis, CXCR3 ligands have recently been associated with 
angiostasis.
Finally, responsiveness of structural cells towards rel-
evant chemokine ligands was pertussis toxin-sensitive, 
indicating the necessity of G(i) alpha protein-coupled 
receptor signaling for chemokine-induced wound repair 
in vitro.
The chemokine network in human cutaneous wound 
healing
To confirm findings in mouse and in vitro observations 
with human structural cells, we studied the kinetics 
of human secondary wound healing in  vivo (Fig.  5; 
Table 3). Immunohistochemical analyses of chemokine 
Fig. 4 Chemokines enhance wound repair in vitro. Wound repair 
of a single path wound in a confluent culture of human primary 
keratinocytes, in the presence of chemokine CCL20 or medium alone 
(control) was monitored by time‑lapse video microscopy for 18 h 
after injury. 0 h, monolayers immediately after injury; 18 h, keratino‑
cyte monolayer with CCL20/MIP‑3α (100 ng/ml) was nearly closed 
compared to control. Magnification ×150. The scale corresponds to 
50 µm. Representative results of at least three independent experi‑
ments
Table 2 Chemokines enhance wound repair in vitro
Wound repair of single path wounds in confluent cultures of human primary dermal microvascular endothelial cells, dermal fibroblasts and epidermal keratinocytes 
in the presence of indicated chemokines was monitored 12–18 h after injury. Percentage of wound closure was normalized to medium alone. Experiments were 
performed in triplicates and representative results of three different donors are shown. (−, closure of wound under 10%; n.d., not determined; ×, no receptor 
expressed for this ligand)
ng/ml Endothelial cells Fibroblasts Keratinocytes
10 100 500 1000 10 100 500 1000 10 100 500 1000
CCL1/I‑309 40% 40% 60% n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
CCL3/MIP‑1α × × × × – – – – × × × ×
CCL11/eotaxin – 50% 100% 80% 30% 30% 50% – 40% 40% 70% 60%
CCL17/TARC – – – n.d. 50% 60% 50% – – 70% 40% 30%
CCL20/MIP‑3α – – – n.d. × × × × 100% 80% 60% 30%
CCL27/CTACK – 40% 100% 80% 100% 70% 50% 80% – – – n.d.
CXCL8/IL‑8 40% – – n.d. × × × × 50% 80% 70% 80%
CXCL10/IP‑10 – – – n.d. × × × × – 20% 80% 100%
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ligand and receptor expression in skin biopsies taken 
from wound edges on day 0, 2, 5, 7, 10, and 12 after 
radical surgery and secondary wound healing showed 
that structural cells as well as skin-infiltrating leuko-
cytes are sources of abundant chemokine production 
(Fig.  5; Table  3). In addition to resident and skin-
infiltrating leukocytes, structural cells also expressed 
and regulated chemokine receptor expression dur-
ing the healing process. To identify the cellular origin 
of chemokine ligand and receptor expression, serial 
sections were stained with anti-CD3 to identify lym-
phocytes, anti-CD68 for skin- infiltrating monocytes, 
macrophages and dendritic cells or anti-CD31 as a 
marker for endothelial cells. Keratinocyte- and fibro-
blast-derived chemokine and chemokine receptor 
expression was determined by their characteristic phe-
notype and anatomical location.
In normal skin, CCL27 represented the dominant 
chemokine expressed by basal keratinocytes of the epi-
dermis. Other homeostatically but weakly keratino-
cyte-expressed chemokines included CCL1 (basal 
keratinocytes), CCL17 (suprabasal keratinocytes), 
CCL18/DC-CK1 (suprabasal keratinocytes), CXCL8 
(suprabasal keratinocytes), and CXCL10 (basal keratino-
cytes) (Table  3). Interestingly, the most prominent 
expression of CCL1 was associated with the basal lay-
ers of hair follicles. Furthermore, immunohistochemi-
cal analyses revealed that keratinocytes also express 
chemokine receptors constitutively. Basal keratinocytes 
of normal epidermis markedly expressed CXCR3 on their 
Fig. 5 Chemokine expression during cutaneous wound healing. Immunohistochemical analyses of chemokine expression in healthy versus 
wounded human skin. Kryo sections (6 μm) of healthy and skin undergoing secondary wound healing (2, 5, 7 and 12 days after wounding) were 
stained with antibodies directed against CXCL9/Mig (a–d), CXCR3 (e–h), CCR2α (i), CCR2β (k), CCL1/I‑309 (l), CCR8 (m), CCL27/CTACK (n), CCR10 (o), 
CXCL12/SDF‑1α (p), and CXCR4 (q). a, e Healthy skin; b, f, i, day 2 after injury; c, g, l, q day 7 after injury; d, h, k, m–p, day 12 after injury; magnifica‑
tion 100 or ×250. The wound edge points to the right border of the picture. The arrow marks the beginning of the neo‑epidermis. Representative 
results of four different donors
Page 10 of 17Bünemann et al. Eur J Med Res  (2018) 23:4 
Ta
bl
e 
3 
Im
m
un
oh
is
to
ch
em
ic
al
 a
na
ly
si
s 
of
 c
he
m
ok
in
e 
ex
pr
es
si
on
 in
 h
ea
lt
hy
 s
ki
n 
co
m
pa
re
d 
w
it
h 
in
ju
re
d 
hu
m
an
 s
ki
n
G
en
es
N
or
m
al
 s
ki
n
D
ay
 2
 p
.o
.
D
ay
 5
 p
.o
.
D
ay
 9
 p
.o
.
D
ay
 1
2 
p.
o.
G
en
es
N
or
m
al
 s
ki
n
D
ay
 2
 p
.o
.
D
ay
 5
 p
.o
.
D
ay
 9
 p
.o
.
D
ay
 1
2 
p.
o.
CC
R1
N
eu
tr
op
hi
l
−
−
−
−
−
CC
L1
N
eu
tr
op
hi
l
−
−
−
−
−
M
ac
ro
ph
ag
e
+
++
++
+
+
I‑3
09
M
ac
ro
ph
ag
e
−
−
−
−
−
Ly
m
ph
oc
yt
e
−
−
−
−
−
Ly
m
ph
oc
yt
e
−
−
−
−
−
Ke
ra
tin
oc
yt
e
−
−
−
−
−
Ke
ra
tin
oc
yt
e
+
+
+
+
+
Fi
br
ob
la
st
−
−
−
−
−
Fi
br
ob
la
st
−
−
−
−
−
En
do
th
el
ia
l c
el
l
−
−
−
−
−
En
do
th
el
ia
l c
el
l
++
++
+
++
+
++
+
++
CC
R2
α
N
eu
tr
op
hi
l
−
−
−
−
−
CC
L4
N
eu
tr
op
hi
l
−
−
−
−
−
M
ac
ro
ph
ag
e
−
−
−
−
−
M
IP
‑1
β
M
ac
ro
ph
ag
e
+
++
++
+
+
Ly
m
ph
oc
yt
e
−
−
−
−
−
Ly
m
ph
oc
yt
e
−
−
−
−
−
Ke
ra
tin
oc
yt
e
−
−
−
−
−
Ke
ra
tin
oc
yt
e
−
−
−
−
−
Fi
br
ob
la
st
−
−
−
−
−
Fi
br
ob
la
st
−
−
−
−
−
En
do
th
el
ia
l c
el
l
+
++
++
+
+
En
do
th
el
ia
l c
el
l
+
++
+
+
+
CC
R2
β
N
eu
tr
op
hi
l
−
−
−
−
−
CC
L1
1
N
eu
tr
op
hi
l
−
−
−
−
−
M
ac
ro
ph
ag
e
+
++
++
+
+
eo
ta
xi
n
M
ac
ro
ph
ag
e
−
−
−
−
−
Ly
m
ph
oc
yt
e
−
+
+
+
+
Ly
m
ph
oc
yt
e
−
−
+
+
+
Ke
ra
tin
oc
yt
e
−
−
−
−
−
Ke
ra
tin
oc
yt
e
−
−
−
−
−
Fi
br
ob
la
st
−
−
−
−
−
Fi
br
ob
la
st
+
++
++
++
+
++
En
do
th
el
ia
l c
el
l
−
−
−
−
−
En
do
th
el
ia
l c
el
l
+
+
++
+
++
+
+
CC
R3
N
eu
tr
op
hi
l
−
−
−
−
−
CC
L1
7
N
eu
tr
op
hi
l
−
−
−
−
−
M
ac
ro
ph
ag
e
−
−
−
−
−
TA
RC
M
ac
ro
ph
ag
e
−
−
−
−
−
Ly
m
ph
oc
yt
e
−
+
++
++
+
Ly
m
ph
oc
yt
e
−
−
−
−
−
Ke
ra
tin
oc
yt
e
+
+
+
+
+
Ke
ra
tin
oc
yt
e
+
++
++
+
+
Fi
br
ob
la
st
−
+
++
++
+
Fi
br
ob
la
st
−
−
−
−
−
En
do
th
el
ia
l c
el
l
+
+
++
++
+
En
do
th
el
ia
l c
el
l
+
++
+
++
+
++
+
CC
R4
N
eu
tr
op
hi
l
−
−
−
−
−
CC
L1
8
N
eu
tr
op
hi
l
−
−
−
−
−
M
ac
ro
ph
ag
e
−
−
−
−
−
D
C‑
CK
1
M
ac
ro
ph
ag
e
−
+
+
+
−
Ly
m
ph
oc
yt
e
−
−
++
++
+
Ly
m
ph
oc
yt
e
−
−
−
−
−
Ke
ra
tin
oc
yt
e
+
+
+
+
+
Ke
ra
tin
oc
yt
e
+
++
++
++
+
Fi
br
ob
la
st
−
−
+
−
−
Fi
br
ob
la
st
−
−
−
−
−
En
do
th
el
ia
l c
el
l
+
+
++
++
+
En
do
th
el
ia
l c
el
l
−
−
−
−
−
CC
R5
N
eu
tr
op
hi
l
−
−
−
−
−
CC
L2
0
N
eu
tr
op
hi
l
−
−
−
−
−
M
ac
ro
ph
ag
e
−
−
−
−
−
M
IP
-3
α
M
ac
ro
ph
ag
e
−
−
−
−
−
Ly
m
ph
oc
yt
e
−
−
−
−
−
Ly
m
ph
oc
yt
e
−
−
−
−
−
Ke
ra
tin
oc
yt
e
−
−
−
−
−
Ke
ra
tin
oc
yt
e
+
++
++
+
++
+
++
Fi
br
ob
la
st
−
−
−
−
−
Fi
br
ob
la
st
−
−
−
−
−
Page 11 of 17Bünemann et al. Eur J Med Res  (2018) 23:4 
Ta
bl
e 
3 
co
nt
in
ue
d
G
en
es
N
or
m
al
 s
ki
n
D
ay
 2
 p
.o
.
D
ay
 5
 p
.o
.
D
ay
 9
 p
.o
.
D
ay
 1
2 
p.
o.
G
en
es
N
or
m
al
 s
ki
n
D
ay
 2
 p
.o
.
D
ay
 5
 p
.o
.
D
ay
 9
 p
.o
.
D
ay
 1
2 
p.
o.
En
do
th
el
ia
l c
el
l
−
−
−
−
−
En
do
th
el
ia
l c
el
l
−
−
−
−
−
CC
R6
N
eu
tr
op
hi
l
−
−
−
−
−
CC
L2
4
N
eu
tr
op
hi
l
−
−
−
−
−
M
ac
ro
ph
ag
e
−
−
−
−
−
eo
ta
xi
n-
2
M
ac
ro
ph
ag
e
−
−
−
−
−
Ly
m
ph
oc
yt
e
−
−
−
−
−
Ly
m
ph
oc
yt
e
−
−
−
−
−
Ke
ra
tin
oc
yt
e
++
++
++
++
++
Ke
ra
tin
oc
yt
e
−
−
−
−
−
Fi
br
ob
la
st
−
−
−
−
−
Fi
br
ob
la
st
−
−
−
−
−
En
do
th
el
ia
l c
el
l
−
++
++
++
++
En
do
th
el
ia
l c
el
l
+
+
++
++
+
CC
R8
N
eu
tr
op
hi
l
−
−
−
−
−
CC
L2
7
N
eu
tr
op
hi
l
−
−
−
−
−
M
ac
ro
ph
ag
e
+
++
++
+
+
CT
AC
K
M
ac
ro
ph
ag
e
−
−
−
−
−
Ly
m
ph
oc
yt
e
−
+
+
+
+
Ly
m
ph
oc
yt
e
−
−
−
−
−
Ke
ra
tin
oc
yt
e
−
−
−
−
−
Ke
ra
tin
oc
yt
e
+
++
+
+
+
Fi
br
ob
la
st
−
−
−
−
−
Fi
br
ob
la
st
−
−
−
−
−
En
do
th
el
ia
l c
el
l
+
+
++
++
+
En
do
th
el
ia
l c
el
l
−
−
−
−
−
CC
R1
0
N
eu
tr
op
hi
l
−
−
−
−
−
C
XC
L8
N
eu
tr
op
hi
l
−
−
−
−
−
M
ac
ro
ph
ag
e
−
−
−
−
−
IL-
8
M
ac
ro
ph
ag
e
−
−
−
−
−
Ly
m
ph
oc
yt
e
−
+
++
++
++
Ly
m
ph
oc
yt
e
−
−
−
−
−
Ke
ra
tin
oc
yt
e
−
−
−
−
−
Ke
ra
tin
oc
yt
e
+
++
+
++
++
+
Fi
br
ob
la
st
−
−
−
−
−
Fi
br
ob
la
st
−
−
−
−
−
En
do
th
el
ia
l c
el
l
++
+
++
+
++
++
En
do
th
el
ia
l c
el
l
+
++
++
++
+
C
XC
R1
N
eu
tr
op
hi
l
−
−
−
−
−
C
XC
L9
N
eu
tr
op
hi
l
−
−
−
−
−
M
ac
ro
ph
ag
e
−
−
−
−
−
M
ig
M
ac
ro
ph
ag
e
−
++
+
++
+
−
Ly
m
ph
oc
yt
e
−
−
−
−
−
Ly
m
ph
oc
yt
e
−
−
−
−
−
Ke
ra
tin
oc
yt
e
+
+
+
+
+
Ke
ra
tin
oc
yt
e
+
+
+
+
+
Fi
br
ob
la
st
−
−
−
−
−
Fi
br
ob
la
st
−
−
−
−
−
En
do
th
el
ia
l c
el
l
+
++
++
++
+
En
do
th
el
ia
l c
el
l
−
−
−
−
−
C
XC
R2
N
eu
tr
op
hi
l
−
+
+
−
−
C
XC
L1
0
N
eu
tr
op
hi
l
−
−
−
−
−
M
ac
ro
ph
ag
e
−
−
−
−
−
IP
‑1
0
M
ac
ro
ph
ag
e
−
−
−
−
−
Ly
m
ph
oc
yt
e
−
−
−
−
−
Ly
m
ph
oc
yt
e
−
−
−
−
−
Ke
ra
tin
oc
yt
e
+
+
+
+
+
Ke
ra
tin
oc
yt
e
+
+
+
+
+
Fi
br
ob
la
st
−
−
−
−
−
Fi
br
ob
la
st
−
−
−
−
−
En
do
th
el
ia
l c
el
l
−
++
++
−
−
En
do
th
el
ia
l c
el
l
−
+
++
+
−
C
XC
R3
N
eu
tr
op
hi
l
−
−
−
−
−
C
XC
L1
2
N
eu
tr
op
hi
l
−
−
−
−
−
M
ac
ro
ph
ag
e
−
−
−
−
−
SD
F-
1α
M
ac
ro
ph
ag
e
+
++
+
++
+
++
+
Ly
m
ph
oc
yt
e
−
−
−
−
−
Ly
m
ph
oc
yt
e
Ke
ra
tin
oc
yt
e
+
++
++
+
+
+
Ke
ra
tin
oc
yt
e
−
−
−
−
−
Fi
br
ob
la
st
−
−
−
−
−
Fi
br
ob
la
st
−
−
−
−
−
Page 12 of 17Bünemann et al. Eur J Med Res  (2018) 23:4 
Ta
bl
e 
3 
co
nt
in
ue
d
G
en
es
N
or
m
al
 s
ki
n
D
ay
 2
 p
.o
.
D
ay
 5
 p
.o
.
D
ay
 9
 p
.o
.
D
ay
 1
2 
p.
o.
G
en
es
N
or
m
al
 s
ki
n
D
ay
 2
 p
.o
.
D
ay
 5
 p
.o
.
D
ay
 9
 p
.o
.
D
ay
 1
2 
p.
o.
En
do
th
el
ia
l c
el
l
−
−
+
−
−
En
do
th
el
ia
l c
el
l
+
++
++
+
++
+
+
C
XC
R4
N
eu
tr
op
hi
l
−
−
−
−
−
M
ac
ro
ph
ag
e
+
++
+
++
+
+
+
Ly
m
ph
oc
yt
e
+
+
+
+
Ke
ra
tin
oc
yt
e
+
+
+
++
++
Fi
br
ob
la
st
−
−
−
−
−
En
do
th
el
ia
l c
el
l
+
+
+
+
+
Cr
yo
se
ct
io
ns
 (6
 µ
m
) o
f s
ki
n 
sa
m
pl
es
, d
er
iv
ed
 e
ith
er
 fr
om
 h
ea
lth
y 
su
bj
ec
ts
 o
r f
ro
m
 s
ub
je
ct
s 
w
ho
 a
re
 g
oi
ng
 th
ro
ug
h 
an
 a
cn
e 
in
ve
rs
a 
tr
ea
tm
en
t (
2,
 5
, 9
 a
nd
 1
2 
da
ys
 a
ft
er
 tr
au
m
a)
 w
ith
 s
ec
on
da
ry
 w
ou
nd
 h
ea
lin
g 
w
er
e 
st
ai
ne
d 
w
ith
 a
nt
ib
od
ie
s 
di
re
ct
ed
 a
ga
in
st
 th
e 
lis
te
d 
ch
em
ok
in
e 
an
d 
ch
em
ok
in
e 
re
ce
pt
or
s. 
Re
pr
es
en
ta
tiv
e 
re
su
lts
 fr
om
 fo
ur
 d
iff
er
en
t d
on
or
s. 
+,
 w
ea
k;
 +
+,
 m
od
er
at
e;
 +
++
, s
tr
on
g 
st
ai
ni
ng
Page 13 of 17Bünemann et al. Eur J Med Res  (2018) 23:4 
cell surface (Fig. 5e). During cell differentiation, keratino-
cytes appeared to lose CXCR3 but gained CXCR4 
expression resulting in  CXCR3−/CXCR4+ suprabasal 
keratinocytes in healthy skin (Fig. 5q). Similar to CXCR3, 
CCR6 was expressed at high levels in basal keratinocytes 
of healthy skin (Table  3). Other chemokine receptors 
which were expressed at lower levels by keratinocytes in 
normal skin were CCR3 (basal and suprabasal keratino-
cytes), CCR4 (suprabasal keratinocytes), and CXCR1 
(suprabasal keratinocytes) (Table 3).
Next to keratinocytes, dermal endothelial cells also 
showed abundant homeostatic chemokine ligand (CCL1, 
CCL17, CCL24, CXCL12) and receptor (CCR2α, CCR3, 
CCR4, CCR8, CCR10, CXCR1, CXCR2, CXCR3) expres-
sion confirming our previous in vitro results.
After cutaneous injury, monocytes infiltrate the skin, 
get activated, and differentiate into macrophages and 
dendritic cells expressing CCR1, CCR2β, CCR6, CCR8, 
and CXCR4 (Fig. 5; Table 3). CD3-positive lymphocytes, 
which were present as early as 2  days after injury and 
reside in perivascular pockets demarcating the wound 
bed, expressed a variety of chemokine receptors includ-
ing CCR3, CCR4, CCR6, CCR8, CCR10, CXCR3, and 
CXCR4 (Table 3).
Two days after wounding, keratinocytes of the wound 
edge migrate into the wound bed and start to form a neo-
epidermis. Basal keratinocytes of the neo-epidermis are 
strong producers of CCL27 throughout the re-epitheli-
alization period. Next to CCL27, basal keratinocytes of 
the neo-epidermis also show low levels of CCL1 expres-
sion (Fig. 5l, n). Overall weak expression of CXCL10 was 
detected in keratinocytes bordering or distant to the 
wound edge (Table 3). During resurfacing of the wound, 
keratinocytes migrate as a collective with basal cells 
leading the way. Interestingly, CCR6 and CXCR3 were 
also highly expressed in this subset of migrating basal 
keratinocytes (Table  3). Suprabasal keratinocytes of the 
neo-epidermis were also an abundant source of CCL18, 
CCL20 and CXCL8 and expressed low levels of CCR3, 
CCR4, and CXCR1 on their cell surface (Table 3). During 
tissue remodeling (> day 10), the neo-epidermis reorgan-
ized and started to show stratified receptor expression 
with CXCR3 on basal and strong CXCR4 expression 
on differentiating suprabasal keratinocytes (Fig.  5e–h; 
Table 3).
CD68+ leukocytes were seen at perivascular pockets 
delimiting the wound bed and in close proximity to the 
developing neo-epidermis. This population of skin infil-
trating monocytes, activated macrophages and dendritic 
cells was an abundant source of CCL18, CXCL9, and 
CXCL12 (Fig. 5a–d, p; Table 3).
Starting from day 4 after injury, endothelial cells infil-
trate the wound bed along provisional extracellular 
matrix. Wound-infiltrating endothelial cells expressed a 
broad spectrum of chemokine receptors, such as CCR3, 
CCR4, CCR6, CCR8, CCR10, CXCR1, CXCR2, CXCR3, 
and CXCR4 (Fig. 5; Table 3). CCR6 was the most domi-
nant chemokine receptor expressed on endothelial 
cells after day 10 of wound healing (Table  3). Endothe-
lial cells of the wound edge and those infiltrating the 
wound also produced a variety of chemokines includ-
ing CXCL8, CXCL10, CXCL12, and CCL24 (Table  3). 
Although cultured microvascular endothelial cells did 
not express significant levels of CCR2 in vitro, antibod-
ies raised against the splice variant CCR2α showed 
strong expression of CCR2 on endothelial cells (Fig.  5i; 
Table  3). An antibody directed against another isoform 
of CCR2 (CCR2β) showed a different staining pattern 
with dominant immunoreactivity on  CD68+ leukocytes 
(Fig.  5k; Table  3). Another chemokine which has previ-
ously been shown to be expressed by endothelial cells, 
CCL17, was found to be expressed in human secondary 
wounds by keratinocytes and endothelial cells around day 
5 (Table 3). CCR4, receptor of CCL17, was homeostati-
cally expressed on suprabasal keratinocytes in healthy 
and wounded skin (Table  3). Furthermore, CCR4 could 
be detected on endothelial cells within the wound bed 
confirming in vitro findings with cultured microvascular 
endothelial cells (Additional file 1: Figure S3).
In summary, our findings in human secondary wound 
healing confirm both our initial observations in mice 
and in  vitro results, and suggest several autocrine and 
heterocrine loops of chemokine-induced cell activation 
and suggest a temporal–spatial chemokine ligand and 
receptor expression which may regulate biological pro-
cesses including cell migration during cutaneous wound 
healing.
Discussion
In recent years, several mediators including cytokines 
and chemokines have been suggested to participate in 
the process of wound healing [1, 2, 17, 18]. So far, most 
reports have mainly focused on the role of single mol-
ecules or single ligand–receptor combinations and com-
prehensive studies are missing. The rapid discovery of 
the complete chemokine superfamily offers the opportu-
nity to take a “global view” in order to identify all family 
members of a particular molecular family involved in a 
biological process.
In the present study, we systematically investigated 
the potential role of several members of the chemokine 
superfamily in cutaneous wound healing, characterized 
their cellular origin as well as their regulation by proin-
flammatory mediators and their putative function. We 
have performed the analysis of the chemokine network 
on the mRNA- and also on the protein level, and secondly 
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we investigated mouse and human wound healing mod-
els in  vitro and in  vivo. Our results suggest a complex 
interplay of structural cells via chemokine ligand–recep-
tor interactions and we identified several members of the 
chemokine superfamily as being among the most highly 
regulated genes during cutaneous wound healing.
Cutaneous wound healing occurs via sequential over-
lapping phases starting with the injury and consecu-
tive with the hemostasis followed by inflammation, 
re-epithelization, granulation tissue- formation and 
finally tissue remodeling. Within hours after tissue injury, 
neutrophils are recruited to cleanse the wound of foreign, 
potentially infectious particles [1, 2]. Neutrophil infiltra-
tion into the wound is followed by an influx of monocytes 
which differentiate to activated macrophages and release 
an array of growth factors such as platelet-derived growth 
factor (PDGF) and vascular endothelial growth factor 
(VEGF) together with chemoattractants initiating the 
formation of granulation tissue [1, 2]. Among the leuko-
cyte subsets infiltrating cutaneous wounds, macrophages 
and macrophage-derived factors have been shown to play 
a pivotal role in the transition from inflammation to tis-
sue repair since macrophage-depleted animals exhibit 
defective wound repair [4, 5]. In this phase, a plethora of 
cytokines along with chemokines is released. Chemokines 
such as CCL2, CCL3, CCL4 and CCL5 are candidates to 
mediate monocyte/macrophage recruitment to wound 
sites via CCR1, 2, 3 and 5 [2, 3, 26]. Our findings con-
firmed strong CCL2, CCL3 and CCL4 expression dur-
ing the inflammatory phase of mouse wound healing and 
show matching temporal expression of their main recep-
tors CCR1 and CCR2 on wound-associated  CD68+ mac-
rophages [2]. Macrophages and dendritic cells are also an 
abundant source of chemokine ligands during cutaneous 
wound healing. In humans, macrophages and dendritic 
cells at wound sites secrete high levels of CCL18, CXCL9, 
12 and CXCL22. In fact, previous findings in arterioscle-
rosis and lung diseases support strong CCL18 expression 
by lesional macrophages and dendritic cells [27–29].
Our observations also suggest that other mono-
cyte/macrophage chemoattractants such as CCL1 and 
CXCL12 may be involved in the recruitment of CCR8/
CXCR4-positive macrophages/dendritic cells during the 
inflammation and the transition to the tissue formation 
phase of cutaneous wound healing. However, this is in 
contrast to the more recent results of Zheng L et al. who 
described CXCL8 and CCL2 as important chemokines in 
the inflammation phase and hemostasis phase produced 
by macrophages [30]. Our immunohistochemical analysis 
of acne inversa patients showed no significant expression 
of CXCL8 in macrophages but particularly in keratino-
cytes and endothelial cells, with a high expression of 
CXCL8 after 2 days.
The influx of macrophages is followed by the infiltra-
tion of lymphocytes into the wound site around days 
[2, 3]. Lymphocytes remain in the demarcating zone for 
the entire wound healing process while the majority of 
neutrophils and macrophages disappear after the for-
mation of granulation tissue. Strikingly, a large variety 
of lymphocyte chemoattractants such as CCL1, CCL2, 
CCL3, CCL4, CCL5, CCL7, CCL11, CCL18/DC-CK, 
CCL20, CCL24, CCL27, CXCL9, CXCL10, CXCL12, 
and XCL1 are present during the inflammation and tis-
sue formation phase of wound healing. Correspond-
ingly, a strong expression of CCR2, CCR3, CCR6, CCR8, 
CCR10, CXCR3 and CXCR4 can be detected on the sur-
face of  CD3+ lymphocytes at wound sites. In summary, 
the immune system provides multiple and redundant 
mechanisms to attract lymphocytes to sites of injury and 
tissue repair. Yet, their precise role during tissue forma-
tion and remodeling, besides representing sentinels of 
the immune system, is currently not well understood. 
In this context, the predominant presence of  CD3+ lym-
phocytes in the perivascular pockets of sprouting blood 
vessels during cutaneous wound healing points toward a 
possible role in supporting endothelial cell proliferation, 
migration and invasion.
Tissue granulation and re-epithelialization of the 
wound bed are the next important processes dur-
ing wound healing. Within days after injury, the phe-
notype of keratinocytes of the wound edge markedly 
changes. In fact, the cells reorganize their cytoskeleton, 
dissolve intercellular desmosomes, loose hemidesmo-
somal links between the epidermis and the dermis, and 
upregulate integrin receptors [1]. Altogether, these pro-
cesses enable keratinocytes to migrate along viable 
tissue into the wound bed. However, the stimuli deter-
mining the migration of keratinocytes during the for-
mation of a neo-epidermis have not been completely 
elucidated yet. The in  vitro findings presented in this 
study show that human keratinocytes express a distinct 
set of functionally active chemokine receptors includ-
ing CCR3, CCR4, CCR6, CXCR1, CXCR2, CXCR3 on 
their cell surface. Ligands to particular receptors sig-
nificantly enhance keratinocyte migration and promote 
wound repair in  vitro. Chemokine receptor expression 
by keratinocytes was confirmed in  vivo during human 
secondary wound healing pointing to several important 
chemokine ligand–receptor combinations in the process 
of re- epithelialization.
In normal skin, basal keratinocytes express high levels 
of CXCR3 on their cell surface. Yet, CXCR3 expression 
of keratinocytes appears to be differentiation-dependent 
since suprabasal keratinocytes of the stratum spinosum 
or granulosum loose CXCR3 expression. In contrast, dif-
ferentiating keratinocytes gain CXCR4 expression in vivo. 
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Previously, immunohistochemical analyses of Charbon-
nier et  al. suggested CCR6 expression by keratinocytes 
but the biological function remained unclear [31]. Here, 
we have shown that signaling through CCR6 can enhance 
keratinocyte wound repair in vitro.
In vitro, CCL27 markedly enhanced wound repair 
of endothelial cell and fibroblast indicating a role for 
CCL27–CCR10 interactions in tissue repair.
Approximately, 4  days after injury granulation tis-
sue invades the wound bed. Fibroblasts start to produce 
a provisional matrix composed of fibrin, fibronectin, 
and hyaluronic acid, which is necessary to support cell 
ingrowth [1]. Cell movement into this matrix may require 
proteolytic functions which are provided by matrix-met-
alloproteinases such as plasmin, plasminogen activator, 
collagenase, gelatinase A or stromelysin, which are mark-
edly upregulated between days 2 and 5 and may cleave a 
path for cell migration. Previous studies showed CCL2-
induced matrix-metalloproteinase induction in dermal 
fibroblasts [32]. Although we could not detect signifi-
cant CCR2 or CCR5 expression, both representing CCL2 
ligands, on cultured fibroblasts, our in  vitro findings 
show that primary dermal fibroblasts markedly express 
CCR3, CCR4, and CCR10 and respond with enhanced 
wound repair after stimulation with their ligands [33]. 
Notably, a broad array of CCR3 ligands, including CCL5, 
CCL7, CCL11 and CCL24, are upregulated in cutaneous 
wound healing suggesting a role for these ligand–recep-
tor interactions in fibroblast biology and the tissue for-
mation phase of the wound healing process.
Angiogenesis represents a complex process depend-
ing on extracellular matrix in the wound bed as well as 
migration and mitogenic stimulation of endothelial 
cells. During recent years, a variety of angiogenic factors 
such as basic fibroblast growth factor (bFGF), vascular 
endothelial growth factor (VEGF), transforming growth 
factor-β (TGF-β), angiogenin, angiotrofin, angiopoi-
etin-1, thrombospondin, low oxygen and elevated lactic 
acid, have been linked to the induction of angiogenesis 
[1]. A current focus of chemokine research represents the 
investigation of the contribution of chemokines toward 
angiogenesis. Certain members of the CXC, e.g. CXCL8 
and more recently also of the CC chemokine family 
induce endothelial cell migration in vitro and angiogen-
esis in  vivo [3, 15, 16, 34–39]. Furthermore, angiogenic 
growth factors such as VEGF and bFGF have recently 
been shown to regulate chemokine receptor expression 
on endothelial cell suggesting a complex relationship of 
growth factors and chemokines in the regulation of angi-
ogenesis [39]. In the present study, we show that human 
dermal microvascular endothelial cells express a distinct 
set of chemokine receptors, such as CCR3, CCR4, CCR6, 
CCR10, CXCR2, CXCR3 in vitro. Moreover, stimulation 
with the respective ligands (CCL1, CCL11, CCL27, 
CXCL8) enhanced wound injury repair of cultured 
endothelial cells. Another set of chemokines including 
CCL17, CCL20 and CXCL10 did not promote injury 
repair although their corresponding receptors (CCR4, 
CCR6 and CXCR3) are markedly expressed on endothe-
lial cells. For other CXCR3 ligands, such as CXCL9, 
CXCL10 and CXCL11, there is accumulating evidence 
that they induce angiostasis through CXCR3 [40].
Bernardini et  al. and Haque et  al. demonstrated that 
the CCR8 ligand CCL1 binds to endothelial cells, stimu-
lates chemotaxis and invasion of these cells, enhances 
human umbilical vein endothelial cell differentiation 
into capillary-like structures in vitro and induces angio-
genesis in vivo [35–37]. Previously, it has been suggested 
that angiogenic ELR-motive-positive chemokines such as 
CXCL8 are expressed during the inflammation and tis-
sue formation phase of wound healing and ELR-motive 
negative angiostatic chemokines such as CXCL10 appear 
later in the wound healing process dominating the tis-
sue remodeling phase [3]. Our findings indicate that 
both angiogenic and angiostatic factors are present at all 
phases of cutaneous wound healing and suggest a more 
complex balance and regulation.
Taken together, chemokines and chemokine receptors 
are expressed in a distinct temporal and spatial manner 
during wound healing and play many different func-
tions during wound healing processes. Our findings elu-
cidate an important role for chemokines in the complex 
wound healing cascade and underscore the central para-
digm that cutaneous injury begins with proinflamma-
tory cytokine and chemokine production which results 
in leukocyte recruitment and subsequent growth factor 
production. In turn, growth factor production by leuko-
cytes and structural cells combined with chemokine sig-
nalling will orchestrate the dynamic process of migration, 
invasion, and proliferation of parenchymal cells for tissue 
repair. Not much has been done in the clinic regarding 
the use of chemokines and their receptors as a basis for 
treatment. Chronic inflammation and alteration in angio-
genesis can potentially be reduced or eliminated by inter-
fering with proinflammatory or angiogenic chemokines 
and their receptors using small molecules that interfere 
with receptor function. To our knowledge, this study 
is the most comprehensive analysis of chemokine and 
chemokine receptor expression both in vivo and in vitro. 
In addition to the extensive analysis of the central struc-
tural and soluble network partners in wound healing, 
our work was able to elucidate previously unknown 
interactions between chemokine ligands and chemokine 
receptors. We were able to gain information on a faster 
wound healing through the use of specific chemokines 
and we revealed patterns of expression that have not 
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been described so far. Especially ligand–receptor sign-
aling through CCR6 can enhance keratinocyte wound 
repair in vitro. CCL27 markedly enhanced wound repair 
of endothelial cell and fibroblast indicating an important 
role for CCL27–CCR10 interactions in tissue repair.
Nevertheless, there are some limitations to this study, 
which are based on the fact that a very special patient col-
lective of the so-called Acne inversa was investigated. To 
support the results of our work, the number of samples 
should be increased and different patient groups should 
be examined in subsequent studies. The selection of the 
test mice can also contribute to the results. We have only 
examined female BALB/c mice in our work. However, 
recently published studies suggest that wound healing in 
female BALB/c mice may differ from male mice [41]. To 
achieve a positive therapeutic effect, the exact interac-
tion and influence of certain parts of this complex wound 
healing network must be examined in following work.
In conclusion, our findings enhance the understand-
ing of the underlying mechanisms for cutaneous wound 
healing and may impact the development of novel thera-
peutic strategies for the treatment of wound healing dis-
orders such as chronic ulcers.
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